SG3 Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

SG3 Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-22,000	Closed	-$1.64M	–	1029
2021 Q3	$1.64M	Buy	+22,000	New	+$1.85M	0.05%	346
2021 Q2	–	Sell	-20,000	Closed	-$1.77M	–	1012
2021 Q1	$1.77M	Sell	20,000 -159,000	-89%	-$15.8M	0.04%	445
2020 Q4	$16.7M	Buy	+179,000	New	+$14.3M	0.32%	64

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SG3 Management's ARKG Position: Q3 2021 in Review

SG3 Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 12,000 shares — an estimated $1.01M sold.

SG3 Management first reported a position in ARKG in Q4 2020 and held it in 3 quarters. The position peaked at $22.8M in Q4 2020. 469 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

SG3 Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
SG3 Management sold 12,000 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $1.01M.
SG3 Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 3 quarters.
SG3 Management's ARK Genomic Revolution ETF position peaked at $22.8M in Q4 2020.
469 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.